A clinical Safety Study of the medicinal product Monofer given into a vein and administered by a High Dosing Regimen in patients with Inflammatory Bowel Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-003121-94

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the study is to evaluate the safety of a high IV iron dosing regimen of iron iso-maltoside 1000 in subjects with IDA secondary to IBD.


Critère d'inclusion

  • Inflammatory Bowel Disease (IBD)